Cost [qnco]
therapy [ftcn]
SsuE [moft]
Plasminogen [aapp, bacs, phsu]
Compared [acty]
Streptokinase [aapp, enzy, phsu]
Acute myocardial infarction [dsyn]
Background [cnce]
Patients [podg]
Acute myocardial infarction [dsyn]
treated [topp]
Accelerated [ftcn]
Tissue Plasminogen Activator [aapp, enzy, phsu]
GIVEN [cnce]
Conventional [qlco]
hours [tmco]
Two [qnco]
Third [qnco]
Dose [qnco]
GIVEN [cnce]
First [qnco]
Mortality [qnco]
Percent [qnco]
Lower [spco]
Patients [podg]
treated [topp]
Streptokinase [aapp, enzy, phsu]
Global [spco]
utilization [ftcn]
Streptokinase [aapp, enzy, phsu]
Tissue Plasminogen Activator [aapp, enzy, phsu]
occluded [patf]
Coronary Arteries [bpoc]
Study [mnob]
This [euka]
Equivalent [qlco]
Absolute [qlco]
Decrease [qlco]
Percent [qnco]
Mortality [qnco]
To [qlco]
Assess [acty]
Tissue Plasminogen Activator [aapp, enzy, phsu]
Compared [acty]
Streptokinase [aapp, enzy, phsu]
Cost Effectiveness [qnco]
Methods [inpr]
Primary [qlco]
base [inch]
Case [ftcn]
Analysis [lbpr]
Cost Effectiveness [qnco]
Data [idcn]
Study [mnob]
Life Expectancy [grpa]
Projected [inpr]
Records [inpr]
Survivors [podg]
Myocardial Infarction [dsyn]
CARDIOVASCULAR [bdsy]
Database [inpr]
Primary [qlco]
Analysis [lbpr]
Assumed [inpr]
Additional [ftcn]
treatment [ftcn]
Cost [qnco]
Tissue Plasminogen Activator [aapp, enzy, phsu]
First [qnco]
Survival [acty]
Benefit [qnco]
Tissue Plasminogen Activator [aapp, enzy, phsu]
Evidence [ftcn]
One [qnco]
Enrollment [hlca]
Result [ftcn]
One [qnco]
Enrollment [hlca]
Patients [podg]
Received [qlco]
Tissue Plasminogen Activator [aapp, enzy, phsu]
High [qlco]
Costs [qnco]
High [qlco]
Survival Rate [qnco]
Increase [ftcn]
Percent [qnco]
Patients [podg]
treated [topp]
Streptokinase [aapp, enzy, phsu]
treated [topp]
Patients [podg]
Projected [inpr]
Life Expectancy [grpa]
treatment [ftcn]
Group [idcn]
Incremental [qnco]
Cost Effectiveness [qnco]
Ratio [qnco]
Future [tmco]
Costs [qnco]
Benefits [qnco]
discount [inpr]
Percent [qnco]
Life [idcn]
Save [mcha]
Tissue Plasminogen Activator [aapp, enzy, phsu]
Cost Effectiveness [qnco]
Young [tmco]
Patients [podg]
Most [qnco]
Cost Effectiveness [qnco]
Old [tmco]
Patients [podg]
Age [orga]
Tissue Plasminogen Activator [aapp, enzy, phsu]
Patients [podg]
anterior infarction [dsyn]
More [ftcn]
Favorable [qlco]
Cost Effectiveness [qnco]
Values [qlco]
secondary [neop]
Analysis [lbpr]
Cost Effectiveness [qnco]
Values [qlco]
Most [qnco]
Sensitive [ftcn]
lowering [spco]
Projected [inpr]
Long-term [tmco]
Survival [acty]
Benefit [qnco]
Tissue Plasminogen Activator [aapp, enzy, phsu]
To [qlco]
Moderate [qlco]
increases [ftcn]
Projected [inpr]
Medical [ftcn]
Costs [qnco]
Patients [podg]
Tissue Plasminogen Activator [aapp, enzy, phsu]
Group [idcn]
First [qnco]
Contrast [qlco]
Result [ftcn]
Not [ftcn]
Sensitive to [ftcn]
Very [qlco]
Unfavorable [qlco]
Additional [ftcn]
Costs [qnco]
Associated [qlco]
High [qlco]
Rate [acty]
Stroke [dsyn]
Note [clna]
Patients [podg]
treated [topp]
Tissue Plasminogen Activator [aapp, enzy, phsu]
Study [mnob]
Conclusions [idcn]
Cost Effectiveness [qnco]
treatment [ftcn]
Accelerated [ftcn]
Tissue Plasminogen Activator [aapp, enzy, phsu]
Streptokinase [aapp, enzy, phsu]
Compare [acty]
Therapies [topp]
Added [ftcn]
Medical [ftcn]
Benefit [qnco]
dollars [qnco]
spend [qnco]
Judge [prog]
society [orgt]
